Question: In which State is the Dana-Farber Cancer Institute located?

full_context: Document 1: C. R. Rao: Calyampudi Radhakrishna Rao, FRS known as C R Rao (born 10 September 1920) is an Indian-born, naturalised American, mathematician and statistician. He is currently professor emeritus at Penn State University and Research Professor at the University at Buffalo. Rao has been honoured by numerous colloquia, honorary degrees, and festschrifts and was awarded the US National Medal of Science in 2002. The American Statistical Association has described him as "a living legend whose work has influenced not just statistics, but has had far reaching implications for fields as varied as economics, genetics, anthropology, geology, national planning, demography, biometry, and medicine." "The Times of India" listed Rao as one of the top 10 Indian scientists of all time. Rao is also a Senior Policy and Statistics advisor for the Indian Heart Association non-profit focused on raising South Asian cardiovascular disease awareness.
Document 2: Nilanjan Chatterjee: Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Medicine at the Johns Hopkins University Bloomberg School of Public Health and Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.
Document 3: Broad Institute: The Eli and Edythe L. Broad Institute of MIT and Harvard ( ), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.
Document 4: Rafael Irizarry (scientist): Rafael Irizarry is a professor of biostatistics at the Harvard T.H. Chan School of Public Health and professor of biostatistics and computational biology at the Dana–Farber Cancer Institute. Irizarry is known as one of the founders of the Bioconductor project.
Document 5: Eric Winer: Eric P. Winer, MD (born 1956), is chief of the Division of Women's Cancers and director of the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute in Boston, Massachusetts. He also serves as the Institute's chief strategy officer. He is the Thompson Senior Investigator in Breast Cancer Research and a Professor of Medicine at Harvard Medical School. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He has focused his career on treating patients with breast cancer and advancing understanding of the disease. He is committed to delivering the best care to his patients today while striving to improve the methods of care for the future.
Document 6: Todd Golub: Todd R. Golub is a Professor of Pediatrics at the Harvard Medical School, the Charles A. Dana Investigator in Human Cancer Genetics at the Dana-Farber Cancer Institute, and a founding member of the Broad Institute of MIT and Harvard. He is a world leader in applying genomic tools (such as DNA microarrays) to cancer research, having made important discoveries in the molecular basis of childhood leukemia.
Document 7: Daniel Haber: Daniel A. Haber, Ph.D., M.D. is the director of Massachusetts General Hospital Cancer Center, a Professor of Oncology at Harvard Medical School, and an investigator of the Howard Hughes Medical Institute (HHMI). He earned his B.S. in life sciences and M.S. in toxicology from Massachusetts Institute of Technology, and his M.D. and Ph.D. in biophysics from Stanford University School of Medicine under the mentorship of Robert T. Schimke. He did his postdoctoral training at Massachusetts Institute of Technology with David E. Housman.
Document 8: Dana–Farber Cancer Institute: Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School, and a founding member of Dana–Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.
Document 9: Raúl Rabadán: Raúl Rabadán is an Associate Professor in the Department of Systems Biology and Biomedical Informatics at Columbia University. He is the director of the Center for Topology of Cancer Evolution and Heterogeneity. From 2001 to 2003, Dr. Rabadán was a fellow at the Theoretical Physics Division at CERN, the European Organization for Nuclear Research, in Geneva, Switzerland. In 2003 he joined the Physics Group of the School of Natural Sciences at the Institute for Advanced Study. During 2006-2008, Dr. Rabadán was the Martin A. and Helen Chooljian Member at The Simons Center for Systems Biology at the Institute for Advanced Study in Princeton, New Jersey. He has been named one of Popular Science's Brilliant 10 (2010), a Stewart Trust Fellow (2013), and he received the Harold and Golden Lamport Award at Columbia University (2014). At Columbia, he has put together a highly interdisciplinary lab with researchers from the fields of mathematics, physics, computer science, engineering, and medicine, with the common goal of solving pressing biomedical problems through quantitative computational models. Dr. Rabadán’s current interest focuses on uncovering patterns of evolution in biological systems—in particular, RNA viruses and cancer.
Document 10: David M. Livingston: David M. Livingston is the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana-Farber Cancer Institute. Dr. Livingston joined the Harvard faculty in 1973. His research focuses on breast and ovarian cancer.
Document 11: Spaulding Rehabilitation Hospital: The Spaulding Rehabilitation Hospital is a 132-bed rehabilitation teaching hospital located in Boston, Massachusetts. It is the official teaching hospital for Harvard Medical School’s Department of Physical Medicine and Rehabilitation and the main campus of the Spaulding Rehabilitation Network. The hospital is a member of Partners Continuing Care under Partners HealthCare, a non-profit organization that owns several hospitals in Massachusetts.
Document 12: Harvard Medical School: Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.
Document 13: Marylyn D. Ritchie: Marylyn D. Ritchie is a professor of Biochemistry and Molecular Biology and the director of the Center for Systems Genomics at Penn State University. She has published many papers in peer-reviewed journals such as the American Journal of Human Genetics, the Journal of Biological Chemistry, Human Molecular Genetics, Bioinformatics, and PLOS Genetics. Previously, she was an associate professor at Vanderbilt University in the Department of Molecular Physiology and Biophysics and the Department of Biomedical Informatics. She has also served as a consultant for Boehringer-Ingelheim, one of the world's leading pharmaceutical companies.
Document 14: Massachusetts General Hospital: Massachusetts General Hospital (Mass General or MGH) is the original and largest teaching hospital of Harvard Medical School and a biomedical research facility located in the West End neighborhood of Boston, Massachusetts. It is the third oldest general hospital in the United States and the oldest and largest hospital in New England with 950 beds. With Brigham and Women's Hospital, it is one of the two founding members of Partners HealthCare, the largest healthcare provider in Massachusetts. Massachusetts General Hospital conducts the largest hospital-based research program in the world, with an annual research budget of more than $750 million. It is currently ranked as the #3 hospital in the United States by "U.S. News & World Report".
Document 15: The Jimmy Fund: The Jimmy Fund was founded in 1948 and raises money solely to support adult and pediatric cancer care and research at Dana-Farber Cancer Institute in Boston, Massachusetts.
ground_truth: Massachusetts